Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03928548 · ClinicalTrials.gov registry record
Malnutrition Clinical Characteristics Validation and Staffing Optimization Study (MCC Study)
A clinical trial of Malnutrition, sponsored by Academy of Nutrition and Dietetics.
- Completed
- Registry status
- 887
- Enrollment target
- 2
- Study locations
NCT03928548: Completed study of Malnutrition, sponsored by Academy of Nutrition and Dietetics.
NCT03928548 is a study of Malnutrition that has completed, run by Academy of Nutrition and Dietetics. The registered enrollment target is 887 participants, above the 337-participant average among 17 other Malnutrition trials with a reported enrollment target (163% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03928548, a study of Malnutrition, has completed, sponsored by Academy of Nutrition and Dietetics.
- COMPLETED
- Registry status
- 887 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to establish the validity of the adult and pediatric Malnutrition Clinical Characteristics (MCC). In addition, this project will: examine the relationship between the MCC and an objective measure of body composition; and establish the relationship between in-patient Registered Dietitian Nutritionist (RDN) care and medical outcomes for all in-patients requiring nutrition care, and specifically for malnourished patients. Sixty pediatric and 60 adult in-patient acute care facilities will participate in this research study. The total number of participants enrolled across the 120 facilities will be between 2400-9600. The aims of the study include: 1. Assess the interrater reliability of the MCC. 2. Determine the predictive validity of the adult and pediatric MCC relative to a portfolio of patient medical outcomes. 3. Determine the relationship between the adult and pediatric MCC and body composition measurements conducted via bioelectrical impedance analysis (BIA) in a subset of patients. 4. Identify the utility of BIA for body composition analysis in clinical settings. 5. Estimate the level of RDN care necessary to improve patient outcomes within the portfolio of outcomes. Specifically: quantify the dose (minutes of care and frequency of encounters) of RDN care that is associated with improved medical outcomes in patients already identified as requiring nutrition care, after adjusting for disease severity and other potential confounders. 6. Identify the additional level of RDN care necessary to improve the medical outcomes in patients who have been identified as malnourished using the MCC.
Primary Outcome
Number of days a participant is in-patient at an acute care hospital (discharge date - admission date) as measured by the existing medical record
Conditions Studied
Study Locations (2)
Florida
- AdventHealth - Daytona Beach
Kansas
- The Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 887 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2022-12-31 |
What the finished NCT03928548 record still lists
NCT03928548 is an observational study that tracks outcomes without assigning an intervention. The registered 887 participants enrollment target is mid-sized for trials with a published cap, above the 337-participant average among 17 other Malnutrition trials with a reported enrollment target (163% higher).
The record links to 1 condition, with Malnutrition appearing as the primary indexed condition, and to 0 interventions.
NCT03928548 reports a single indexed study location in Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT03928548 about?
NCT03928548 is a clinical study titled "Malnutrition Clinical Characteristics Validation and Staffing Optimization Study (MCC Study)". The purpose of this study is to establish the validity of the adult and pediatric Malnutrition Clinical Characteristics (MCC). In addition, this project will: examine the relationship between the MCC and an objective measure of body composition; and establish the relationship between in-patient Regi...
What is the current status of trial NCT03928548?
This trial is currently completed. The enrollment target is 887 participants. The study started on 2019-06-24. Estimated completion is 2022-12-31.
What conditions does trial NCT03928548 study?
This clinical trial studies the following conditions: Malnutrition.
Who is sponsoring clinical trial NCT03928548?
This trial is sponsored by Academy of Nutrition and Dietetics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03928548 being conducted?
This trial has 2 study locations across Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malnutrition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03928548's enrollment target sits among peer trials
887 4th of 17 higher than 14 of 17 other Malnutrition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malnutrition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RCT: Early Feeding After PEG Placement
RECRUITING · NA
-
Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
RECRUITING · NA
-
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RECRUITING
-
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
RECRUITING · Phase 4
-
Breath Analysis & Malnutrition
RECRUITING · NA
-
Nutrition in Patient With Critical Limb Ischemia
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI